Search Results

Johannes Broichhagen Group Leader Leibniz Research Institute for Molecular Pharmacology (FMP), Berlin fluorescent ligands for GPCRs, supporting researchers working at the interface of chemical biology and pharmacology masterclasses, and structured engagement opportunities for scientists and biotech leaders working across pharmacology

Paul Insel is Distinguished Professor of Pharmacology and Medicine at the University of California, San Insel's path from medicine to molecular pharmacology 05:15 The origin story — dinner with Al Gilman and on, Paul was hooked and has since studied receptor function in human physiology, receptor molecular pharmacology GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

In 2021, I joined the Ferring Research Institute of Ferring Pharmaceuticals in San Diego as a scientist GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

Johannes Broichhagen is a group leader at the Leibniz Research Institute for Molecular Pharmacology ( By combining fluorophore design, ligand chemistry, and pharmacology, his work enables precise visualization Ecosystem Johannes Broichhagen LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular Pharmacology GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

as they dive into Ian’s unique academic journey—from early interests in medicine to his pivot toward pharmacology GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines strategic leaders seeking new drug development models Anyone curious about where AI meets molecular pharmacology Ajay Yekkirala is a molecular pharmacologist, biotech founder, and scientist whose career has been defined rejection letter pivoted him into a PhD program at the University of Iowa, where he studied opioid pharmacology GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

Jacek Mokrosiński "Jacek is a Senior Scientist at Novo Nordisk specializing in molecular pharmacology GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

.” – Alessandro Nicoli He studied pharmaceutical chemistry in Padua, where his fascination with molecular He obtained an MSc degree in Chemistry and Pharmaceutical Technology from the University of Padua (Italy GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

Nivedha also reflects on broader implications for receptor subtype selectivity, peptide receptor pharmacology , and the evolving role of computational pharmacology in modern drug discovery. Nivedha is a computational biologist specializing in molecular simulations and computational pharmacology Computational approaches provide a mechanistic bridge between receptor structure and pharmacological It also showed me how important GPCR research is in pharmaceutical development.

These studies shaped my future goals as an Assistant Professor in the College of Pharmacy at the University GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

including the CNRS silver medal, the FRM "Young Researcher" prize, the ISI “Highly Cited” and F-1000 in Pharmacology GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

than $10/week Join Premium Below👇 Team Access for Discovery Groups Full University Premium + Terry's Pharmacology Built for teams aligning pharmacology across programs — so everyone works from the same expert-led foundation . $2,249.25/year Per person, min 5 seats ( 25% team discount ) Get Team Access Premium + Terry's Pharmacology Terry Kenakin's pharmacology access with monthly AMA's — the complete GPCR learning experience in one

(s) Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes Drug discovery in the pharmaceutical In this conversation, Arey traces the full arc of how a pharmaceutical research program is born, resourced About the Guest Brian Arey is a pharmacologist and physiologist with over 25 years of pharmaceutical He has led mechanistic pharmacology operations and served as interim head of a 70-person cross-functional research organization spanning mechanistic pharmacology, compound management, and core automation.

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

10 years of experience in the development and management of R&D projects and teams in the field of pharmacology I have developed my expertise in the field of pharmacology and biochemistry of GPCR and the crucial role GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

Angers established his independent research program in the Department of Pharmaceutical Sciences at the Faculty of Pharmacy and the Department of Biochemistry at the University of Toronto. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

Her career has moved through academic pharmacology, a research fellowship in B-cell molecular immunology — why ~250 non-olfactory receptors remain outside clinical attention Career architecture for bench pharmacologists GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

Tall joined the faculty in the Department of Pharmacology and Physiology at the University of Rochester Tall moved to the University of Michigan in 2016 as an Associate Professor of Pharmacology and is a current GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR pharmacologist Dr. 800 receptors, why "non-canonical" GPCRs are nature's own biased receptors, and building a structural pharmacology proteins orchestrate such functional diversity across an entire receptor superfamily remains one of pharmacology's Arun Shukla leads a structural pharmacology lab in the Department of Biological Sciences and Bioengineering GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

How an integrated training and lab structure at Monash Institute of Pharmaceutical Sciences fosters innovation Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute of Pharmaceutical Michelle earned her PhD in Molecular Pharmacology at Monash University, then trained in single-cell biology More about Michelle Halls Monash Institute of Pharmaceutical Sciences Bluesky LinkedIn Articles about GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses

GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses